Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Post by CleverInvestor2on Mar 26, 2020 11:09pm
340 Views
Post# 30851770

Been holding up well

Been holding up well

During Covid-19 pandemic, tril has dropped big time but slowly going back up. Overall, has performed well in this pandemic.

Fundamentals are still there, lots of cash in the bank and big news coming out around June.
Until May, I see this going up to new ATH. Late May/June you'll see some profit taking and the price will drop.... and than it's the moment of truth. Will we head towards $20 or down to $4?
<< Previous
Bullboard Posts
Next >>